M & A
Insight(1/5)
Merck eyes deals, growth through 2013
Merck's CEO sees profit growth from 2010 to 2013 despite looming generic competition for two of its biggest drugs, and has the appetite to buy a big biotechnology company if the right deal comes along. Full Article
Cardinal Health confident of spinoff
Drug wholesaler Cardinal Health remains confident it will be able to spin off its medical-device business next year despite the bleak credit environment, the company's CFO says. Full Article
No obvious candidates for New Star
New Star Asset Management -- seen by many as a possible takeover target -- is not facing an impending bid, board director Richard Pease told Reuters. Full Article
Taking hits in Asia
Private equity firms rushed to Asia in the last few years to cash in on the region's booming economy, only to find a tougher than expected deal climate. The economic slowdown and recent market volatility has made the going even worse. Full Article
Japan concerned over BHP/Rio deal
Japan's antitrust watchdog is expected to raise objections soon to BHP Billiton's $78 billion offer for Rio Tinto, hoping to sway European regulators vetting the global mining sector's biggest takeover. Full Article
The Buzz
- peHUB
- The Deal
Global Deals Data
We do not have the votes. 
Top M&A Stories by Region
- Europe
- Americas
- Asia
M&A News by Industry
Daiichi confident of Effient approval
NEW YORK (Reuters) - Daiichi-Sankyo's top U.S. executive expressed confidence that the blood clot preventer it is developing with Eli Lilly & Co will soon win U.S. approval, and said the sales force for the medicine was champing at the bit to get started. Full Article | Video
Reuters Conferences
| Event | Date | Location |
|---|---|---|
| IFR's Mediterranean Covered Bonds | 27 Nov | Madrid |
| EVCJ's Venture Capital Fundraising Forum | 3 Dec | London |
| Buyouts Texas | 11-12 Dec | Dallas |
